Findings show lower mortality with SGLT-2 inhibitors in a real-life setting Sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs, initially developed to treat type 2 diabetes are associated with a reduced risk of all-cause and cardiovascular death among patients with heart failure in the real-life setting, finds a study published by The ...
SGLT-2 inhibitors may simultaneously tackle kidney stones and gout flare-ups in patients with type 2 diabetes, say researchers Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from ...
And complexity of answers might make them hard to understand without college degree Patients shouldn’t rely on AI powered search engines and chatbots to always give them accurate and safe information on drugs, conclude researchers in the journal BMJ Quality & Safety, after finding a considerable number of answers were wrong or ...
Gap between rich and poor nations has widened over three decades Such inequities may help explain poor cancer outcomes in many lower income countries Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, ...
Investigation raises concerns about excess deaths, missing safety data, questionable effectiveness, and financial ties among expert advisors 7 of the 8 doctors on review panel received direct payments from drug companies The safety and effectiveness of donanemab - an Alzheimer’s drug recently approved by the US Food & Drug Administration ...
The most effective triptans should be promoted globally and guidelines updated accordingly, say researchers Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published by The BMJ today. Triptans work by narrowing blood vessels in the brain and preventing ...
Evidence on antiseizure drugs is inconsistent; but most studies show no heightened risk Findings cast doubt cast on stance taken by UK drugs regulator, say authors Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to ...
Obesity services not deemed a priority, and patients are often victims of prejudice, say experts Obesity treatments are being restricted by cash poor local services across England with many patients being denied specialist drugs, surgery and support, an investigation by The BMJ has found. Patients in nearly half the country can’t get ...
Vaccine should be made available to communities at risk, say researchers One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ today. With mpox infections rising again across the ...
Researchers suggest this could be a first treatment for relieving symptoms of dry eye disease Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today. The researchers suggest that laughter exercise could be an initial treatment ...
Copyright © 2025 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
